For the Inventor, By the Inventor

Enter assignee name

Toronto, Canada

Affinium Pharmaceuticals, Inc.

USPTO Granted Patents = 33

CIPO Patents = 5

Forward Citations = 410

Loading Chart...

Loading Chart...

68 inventors (with patents filed for the assignee):

Mark Andrew Seefeld (15 out of 37 patents)

Kenneth Allen Newlander (15 out of 54 patents)

William Henry Miller (14 out of 73 patents)

4. Irene Nijole Uzinskas (10 out of 16 patents)

5. Dalia R Jakas (9 out of 12 patents)

6. Walter E Dewolf, Jr (7 out of 7 patents)

7. David John Payne (6 out of 21 patents)

8. Judd Berman (4 out of 7 patents)

9. Jailall Ramnauth (4 out of 17 patents)

10. Walter J Burgess (4 out of 4 patents)

11. Joshua M West (4 out of 4 patents)

12. Nicola Gail Wallis (4 out of 59 patents)

13. William F Huffman (4 out of 47 patents)

14. Peter Brent Sampson (3 out of 33 patents)

15. Donald E Awrey (3 out of 3 patents)

33 patents: Sort by Forward Citations

1. 8450307 - Therapeutic agents, and methods of making and using the same (2013-05-28),

2. 8318720 - Acrylamide derivatives as Fab I inhibitors (2012-11-27),

3. 8263613 - Salts, prodrugs and polymorphs of fab I inhibitors (2012-09-11),

4. 8173646 - FAB I inhibitors (2012-05-08),

5. 8153652 - Fab I inhibitors (2012-04-10),

6. 7879872 - Compositions comprising multiple bioactive agents, and methods of using the same (2011-02-01),

7. 7799547 - [object Object] (2010-09-21),

8. 7790716 - Fab I inhibitors (2010-09-07),

9. 7790709 - Heterocyclic compounds, methods of making them and their use in therapy (2010-09-07),

10. 7741339 - Fab I inhibitors (2010-06-22),

11. 7601526 - [object Object] (2009-10-13),

12. 7557125 - Fab I inhibitors (2009-07-07),

13. 7524843 - Fab I inhibitors (2009-04-28),

14. 7422749 - Compounds (2008-09-09),

15. 7250424 - Fab I inhibitors (2007-07-31),

Affinium Pharmaceuticals, Inc. is a bio-pharmaceutical company specializing in the research and development of novel antibiotics for the treatment of serious and life-threatening infections. With a focus on combating resistant bacterial strains, Affinium is dedicated to discovering and delivering innovative therapeutic solutions. For more information about our pipeline and research initiatives, please visit our website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

33 Patents

#36 in Toronto

#383 in Canada

#19,530 in the World

Toronto, Canada

Affinium Pharmaceuticals, Inc.

Forward Citations = 410

68 inventors:

Mark Andrew Seefeld (15 out of 37 patents)

Kenneth Allen Newlander (15 out of 54 patents)

William Henry Miller (14 out of 73 patents)

4. Irene Nijole Uzinskas (10 out of 16 patents)

5. Dalia R Jakas (9 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…